| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A clinical predictive model identifies pediatric patients at risk for eosinophilic esophagitis
|
Borinsky, Stephanie A.
|
|
|
56 |
12 |
p. 2045-2051
|
article
|
| 2 |
A critical appraisal of the safety and efficacy of P-ESWL in treating pancreatic stones
|
Lv, Jianyu
|
|
|
56 |
12 |
p. 2165
|
article
|
| 3 |
Addressing the safety and efficacy of tofacitinib in ulcerative colitis: A response to the TOFA-UC study
|
Shahid, Maryam
|
|
|
56 |
12 |
p. 2172-2173
|
article
|
| 4 |
Adenocarcinoma of the ascending portion of the duodenum
|
Ying, Chun-Lin
|
|
|
56 |
12 |
p. 2154-2155
|
article
|
| 5 |
An unusual polypoid lesion of the rectal ampulla
|
Spinella, Maria Cristina
|
|
|
56 |
12 |
p. 2159-2160
|
article
|
| 6 |
Author's reply: “A critical appraisal of the safety and efficacy of P-ESWL in treating pancreatic stones”
|
Liu, Yu
|
|
|
56 |
12 |
p. 2166-2167
|
article
|
| 7 |
Coagulation factor XI in cirrhosis does not predict thrombo-hemorrhagic complications and hepatic decompensation
|
Zanetto, Alberto
|
|
|
56 |
12 |
p. 2111-2117
|
article
|
| 8 |
Comment on “CAF-derived exosomal lncRNA FAL1 promotes chemoresistance to oxaliplatin by regulating autophagy in colorectal cancer”
|
Wang, YuHan
|
|
|
56 |
12 |
p. 2170-2171
|
article
|
| 9 |
Comment to “Modifiable lifestyle factors, genetic and acquired risk, and the risk of severe liver disease in the UK Biobank cohort (Lifestyle factors and SLD)”
|
Advani, Aman
|
|
|
56 |
12 |
p. 2174-2175
|
article
|
| 10 |
Differences in clinical manifestations and the fecal microbiome between irritable bowel syndrome and small intestinal bacterial overgrowth
|
Lu, Siqi
|
|
|
56 |
12 |
p. 2027-2037
|
article
|
| 11 |
Enhancing the applicability and rigor of precision surgical techniques in laparoscopic hepatectomy
|
Guo, Xiaolong
|
|
|
56 |
12 |
p. 2161-2162
|
article
|
| 12 |
Factors correlated with transmural healing in patients with Crohn's disease in long-term clinical remission on anti-TNF medication
|
Maconi, Giovanni
|
|
|
56 |
12 |
p. 2052-2059
|
article
|
| 13 |
Francesco Salerno, 1947-2024: In Memoriam
|
|
|
|
56 |
12 |
p. 2177-2178
|
article
|
| 14 |
Full Title Page /Editorial Board
|
|
|
|
56 |
12 |
p. i-ii
|
article
|
| 15 |
Graft-to-recipient weight ratio and risk of systemic inflammatory response syndrome early after liver transplantation in children
|
Long, Junshan
|
|
|
56 |
12 |
p. 2118-2124
|
article
|
| 16 |
Higher frequency of gastric neoplasia in advanced chronic liver disease patients: Impact of screening endoscopy in an intermediate-high risk country
|
Morais, Rui
|
|
|
56 |
12 |
p. 2133-2142
|
article
|
| 17 |
Impact of timing of ERCP on long term outcomes of ERCP for acute cholangitis – A single center retrospective study
|
Jagtap, Nitin
|
|
|
56 |
12 |
p. 2149-2153
|
article
|
| 18 |
Incidence and impact of venous thromboembolism in hospitalized patients with acute pancreatitis
|
Keller, Karsten
|
|
|
56 |
12 |
p. 2085-2094
|
article
|
| 19 |
Intrahepatic cholangiocarcinoma with FGFR alterations: A series of Chinese cases with an emphasis on their clinicopathologic and genetic features
|
Zhou, Jun
|
|
|
56 |
12 |
p. 2125-2132
|
article
|
| 20 |
Italian guidelines for the diagnosis and management of colonic diverticulosis and diverticular disease
|
Carabotti, Marilia
|
|
|
56 |
12 |
p. 1989-2003
|
article
|
| 21 |
Metabolic signatures of metabolic dysfunction-associated steatotic liver disease in severely obese patients
|
Babu, Ambrin Farizah
|
|
|
56 |
12 |
p. 2103-2110
|
article
|
| 22 |
Microbiota modulation in disorders of gut-brain interaction
|
Marasco, Giovanni
|
|
|
56 |
12 |
p. 1971-1979
|
article
|
| 23 |
Pioneering applications of immunotherapy in the early stages of hepatocellular carcinoma
|
Eleonora, Alimenti
|
|
|
56 |
12 |
p. 2011-2021
|
article
|
| 24 |
Precision medicine: Externally validated explainable AI support tool for predicting sustainability of infliximab and vedolizumab in ulcerative colitis
|
Konikoff, Tom
|
|
|
56 |
12 |
p. 2069-2076
|
article
|
| 25 |
Predicting the 28-day prognosis of acute-on-chronic liver failure patients based on machine learning
|
Qiu, Shaotian
|
|
|
56 |
12 |
p. 2095-2102
|
article
|
| 26 |
Primary drainage of distal malignant biliary obstruction: A comparative network meta-analysis
|
Lauri, Gaetano
|
|
|
56 |
12 |
p. 2004-2010
|
article
|
| 27 |
Primary sinusoidal-type hepatic angiosarcoma presenting with acute liver failure
|
Leoncini, Giuseppe
|
|
|
56 |
12 |
p. 2156-2158
|
article
|
| 28 |
Psoriasis induced by antiTNF therapy in inflammatory bowel disease: Therapeutic management and evolution of both diseases in a nationwide cohort study
|
Sanz Segura, Patricia
|
|
|
56 |
12 |
p. 2060-2068
|
article
|
| 29 |
Recurrence rate and management after endoscopic papillectomy in a tertiary referral center
|
Dioscoridi, Lorenzo
|
|
|
56 |
12 |
p. 2143-2148
|
article
|
| 30 |
Response to letter to the editor: Enhancing the applicability and rigor of precision surgical techniques in laparoscopic hepatectomy
|
Xu, Zejiang
|
|
|
56 |
12 |
p. 2163-2164
|
article
|
| 31 |
Review: Risk assessment of liver and biliary cancer mortality through detection of high risk polyps at colonoscopies
|
Tariq, Abeera
|
|
|
56 |
12 |
p. 2168-2169
|
article
|
| 32 |
Risk of anti-TNF therapy on pregnancy, breastfeeding, live vaccines and related information in patients with inflammatory bowel disease: Real-world data from a nationwide study
|
Bendaoud, S.
|
|
|
56 |
12 |
p. 2038-2044
|
article
|
| 33 |
Second-line systemic therapy after atezolizumab plus bevacizumab: Is it time to boldly go beyond the known?
|
Giannini, Edoardo G.
|
|
|
56 |
12 |
p. 2077-2078
|
article
|
| 34 |
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma
|
Tovoli, Francesco
|
|
|
56 |
12 |
p. 2079-2084
|
article
|
| 35 |
The evolution of the TIPS placement technique and its applications over four decades
|
Wang, Guangchuan
|
|
|
56 |
12 |
p. 1980-1988
|
article
|
| 36 |
The IBS and SIBO dilemma: Here we go again
|
Marasco, Giovanni
|
|
|
56 |
12 |
p. 2025-2026
|
article
|
| 37 |
Towards an integrated management model for hepatocellular carcinoma
|
Giannini, Edoardo G.
|
|
|
56 |
12 |
p. 2022-2024
|
article
|
Journal description